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In specific cell types infected with the alphaherpesviruses herpes simplex virus and pseudorabies virus (PRV), addition of virus-specific
antibodies results in redistribution of cell-surface-anchored viral proteins. This redistribution is triggered by the viral protein gE and consists of the
directional movement of the antibody–antigen complexes to one pole of the cell. This viral capping process has been associated with increased
antibody-resistant virus spread and strongly resembles immunoreceptor capping, a process that is crucial in activation of different immune cells
(e.g. capping of Fcγ-receptors, B and T cell receptors). Here, we report that the PRV gE-mediated viral capping process results in increased Src
kinase-mediated tyrosine phosphorylation of the cytoplasmic domain of gE and that a fraction of gE associates with lipid rafts, all very reminiscent
of immunoreceptor capping. These results provide evidence that gE-mediated capping is a viral mimicry of immunoreceptor capping.
© 2007 Elsevier Inc. All rights reserved.Keywords: Alphaherpesviruses; Pseudorabies virus; Capping; Glycoprotein E; Tyrosine phosphorylation; Lipid rafts; ImmunoreceptorIntroduction
The alphaherpesvirus subfamily of the herpesviruses con-
sists of closely related members, including herpes simplex virus
(HSV), the porcine pseudorabies virus (PRV), varicella-zoster
virus (VZV), bovine herpesvirus type 1 (BoHV1) and the
equine herpesvirus type 1 (EHV1). PRV is often used as a model
for this subfamily (Pomeranz et al., 2005). Four morphologi-
cally different structural elements can be distinguished in the
PRV virion: the core with the linear double stranded DNA
genome, an icosahedral capsid, an amorphous protein mass
called the tegument and the envelope with imbedded, often
glycosylated envelope proteins. These viral envelope proteins
are expressed in different membranes of the infected cell
(including the plasma membrane). Viral envelope proteins on⁎ Corresponding author. Fax: +32 9 264 74 95.
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doi:10.1016/j.virol.2006.12.018the plasma membrane can be recognized and bound by virus-
specific antibodies, which may trigger antibody-dependent cell
lysis.
In specific cell types (SK, HEL, HEp2) infected with PRVor
HSV-1, binding of virus-specific antibodies to the viral cell
surface proteins results in a particular redistribution of the
antibody–antigen complexes. The antibody–antigen complexes
aggregate quickly and undergo polarization to one pole of the
cell, a process called capping (Favoreel et al., 1997; Rizvi and
Raghavan, 2003). This capping process may impede efficient
elimination of the infected cell by components of the immune
system that can be activated by antibodies (complement,
phagocytes, NK cells) (Favoreel et al., 1997). In addition, the
capping process has been reported to be associatedwith enhanced
cell-to-cell spread of HSV (Rizvi and Raghavan, 2003).
Capping of antibody–antigen complexes on the plasma
membrane of PRV-infected cells strikingly resembles immuno-
receptor capping, one of the initial steps in the activation of
different leukocytes, e.g., Fcγ-receptor capping in monocytes,
macrophages and neutrophils; B-cell receptor capping in B
lymphocytes, and T-cell receptor capping in T-lymphocytes
Fig. 1. Tyrosine phosphorylation of PRV gE. Tyrosine phosphorylation status
(pY) of PRV-infected SK cell lysate (WT, no capping induction; WT, capping
induction; gE null virus, no capping induction) was assessed onWestern blot. gE
expression level was analyzed as a control. *Size of gE.
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family tyrosine kinases and small, dynamic, sterol- and
sphingolipid-enriched domains on the plasma membrane,
which are called lipid rafts, are crucial signaling factors
involved in capping of these different immunoreceptors. In
general, upon triggering of the immunoreceptor (e.g., by IgG
binding, antigen binding, MHC interaction), the immunore-
ceptor oligomerizes and its affinity for lipid rafts increases. The
immunoreceptor is subsequently tyrosine phosphorylated by
Src kinases, generally in its immunoreceptor tyrosine-based
activation motif (ITAM). An ITAM motif consists of two
YXXΦ sequences, where Y is a tyrosine, X can be every amino
acid and Φ is a large hydrophobic residue (often leucine).
Tyrosine phosphorylation of the immunoreceptor initiates a
signaling cascade, eventually leading to capping of the
immunoreceptor-containing lipid rafts and activation of the
leukocyte (Kwiatkowska et al., 2003; Pierce, 2002).
Capping of antibody–antigen complexes in PRV and HSV-
infected cells shows some striking similarities to this process.
Interestingly, capping in both PRV and HSV-infected cells is
mediated by the viral glycoprotein gE (Favoreel et al., 1997;
Rizvi and Raghavan, 2003), a protein that shows IgG binding
Fc-receptor activity in different alphaherpesviruses (Favoreel et
al., 1997; Johnson et al., 1988; Litwin et al., 1992). The
cytoplasmic domain of gE contains ITAM-like YXXΦ
sequences, and mutation of these sequences has been shown
to strongly reduce capping (Favoreel et al., 1999). In addition,
inhibition of tyrosine phosphorylation and disruption of lipid
rafts impairs the viral capping process (Favoreel et al., 1999,
2004). This led us to hypothesize that gE-mediated capping of
antibody–antigen complexes may constitute a viral mimicry of
immunoreceptor capping. To further dissect this hypothesis, in
the current study, we investigated whether gE becomes tyrosine
phosphorylated in its cytoplasmic domain/YXXΦmotifs during
capping, whether Src kinases are involved, and whether gE
associates with lipid rafts during capping.
Results
Tyrosine phosphorylation of PRV gE
As a first step in characterizing the parallel between viral
capping and immunoreceptor capping, we analyzed whether gE
is tyrosine phosphorylated in PRV infected cells. Western blot
analysis of SK cells infected with wild type PRV (Be wt)
revealed a tyrosine phosphorylation band that corresponds with
the size of gE (Fig. 1). Intensity of this band increased
significantly (2.74±0.54 fold), based on three independent
experiments, upon induction of antibody-mediated capping and
the band was not present in cells infected with isogenic gE null
PRV (Fig. 1), indicating that it represents gE. Immunoprecipita-
tion of gE from cells infected with Be wt confirmed that this
tyrosine phosphorylation band represents gE (Fig. 2) and the
strong tyrosine phosphorylation band below the gE band in
Fig. 1 was identified by electrospray tandem mass spectrometry
as the UL47 tegument protein (Desplanques et al., unpublished
data). Thus, gE is tyrosine phosphorylated in PRV infected cellsand tyrosine phosphorylation increases upon induction of
capping.
Tyrosine phosphorylation of the cytoplasmic domain of PRV gE
To determine whether tyrosine phosphorylation of gE occurs
in the cytoplasmic domain/YXXΦ motifs, gE was immunopre-
cipitated from cells inoculated with either Be wt, an isogenic
virus strain lacking the cytoplasmic domain of gE (Be 107) or a
virus strain with mutations in the two YXXΦ motifs in the
cytoplasmic domain of gE (Be 105: Y478S-Y517S). The gE
tyrosine phosphorylation band was completely absent in cells
infected with the virus lacking the cytoplasmic domain of gE,
while it was strongly reduced in intensity in cells infected with
the virus containing point mutations in the YXXΦ motifs in gE
(Fig. 2). To exclude the possibility that the slight remaining gE
phosphorylation signal in cells infected with Be 105 could be
due to recognition of threonine or serine phosphorylation by the
phosphotyrosine-specific antibody, specificity of the phospho-
tyrosine specific monoclonal antibody was tested. The antibody
did not show any reactivity with phosphothreonine-BSA or
phosphoserine-BSA, while it reacted strongly with an identical
amount of phosphotyrosine-BSA (data not shown). This
indicates that the gE phosphorylation signal in cells inoculated
with Be 105 is not due to an aspecific binding of the antibody,
but probably to phosphorylation of additional tyrosine residues
in the cytoplasmic domain of gE.
Fig. 4. A fraction of PRV gE associates with lipid rafts. Lipid rafts were isolated
from PRV infected SK cells by density ultracentrifugation and fractions were
analyzed on Western blot with an anti-gE antibody, with cholera toxin subunit B
hrp conjugate (detection of the raft marker GM1) or an anti-TfR (detection of the
non-raft marker TfR) antibody.
Fig. 2. Tyrosine phosphorylation of PRV gE occurs in the cytoplasmic domain,
at least partly in the YXXΦ motifs. gE tyrosine phosphorylation (pY) was
assessed on Western blot after gE immunoprecipitation out of cell lysate of SK
cells infected with PRV Be WT, PRV Be 105 (Y478S-Y517S) or PRV Be 107
(gE cytoplasmic domain minus). gE expression level was analyzed as a control.
*Size of gE, *′Reduced size of truncated gE (without cytoplasmic domain).
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gE occurs in the cytoplasmic domain, at least partly on the
YXXΦ motifs.
Src kinases play a role in tyrosine phosphorylation of PRV gE
Since Src kinases are pivotal kinases in many signaling
cascades, and since they are responsible for immunoreceptor
tyrosine phosphorylation during immunoreceptor capping and
activation, we assessed whether they are involved in gE tyrosine
phosphorylation.
Capping was induced in the presence of increasing
concentrations of the Src kinase inhibitor PP2 or its negative
control PP3. Treatment of the infected cells with increasing
concentrations of PP2 decreased gE tyrosine phosphorylation in
a dose dependent manner, whereas PP3 treatment did not reduce
tyrosine phosphorylation of gE (Fig. 3). This shows that Src
kinases are critically involved in tyrosine phosphorylation of gE.
Lipid raft association of PRV gE
Lipid rafts play a very important role in immunoreceptor
capping: they form zones of confinement where immunorecep-Fig. 3. Src kinases play a role in tyrosine phosphorylation of gE. gE tyrosine
phosphorylation status (pY) was analyzed after treatment with the Src kinase
inhibitor PP2 or its negative control PP3. gE expression level was analyzed as a
control.tors become tyrosine phosphorylated and further signaling is
induced. Moreover, capping of immunoreceptors and signaling
molecules towards one pole of the cell occurs by the
coalescence of the lipid rafts containing these molecules
(Pierce, 2002). We therefore assessed whether gE associates
with lipid rafts and if so, how this lipid raft association evolves
during the capping process.
Purification of lipid rafts by density ultracentrifugation
revealed that PRV gE shows affinity for lipid rafts: a significant
fraction of the gE protein floats to the lighter fractions of the
gradient (Fig. 4). Western blot analysis of the light and heavy
fractions of the gradient confirmed efficient separation of raft
fractions from non-raft fractions, as a significant portion of the
lipid raft marker GM1 floated to the lighter fractions and nearly
all of the non-lipid raft marker TfR remained at the bottom of
the gradient (Fig. 4).
Although giving a good indication whether a protein has
affinity for lipid rafts or not, purification of lipid rafts by density
ultracentrifugation cannot be used quantitatively to determine
the fraction of individual proteins that is present in rafts
(Shogomori and Brown, 2003). Therefore, to determine whether
or not lipid raft association of gE increases during the capping
process, an alternative fluorescence-based assay was used
(Stuermer et al., 2001), based on colocalization between gE and
the raft marker GM1 during capping. Confocal analysis of gE
and GM1 localization throughout the capping process revealed
that gE colocalizes with the raft marker GM1, especially during
capping (Fig. 5). A quantitative colocalization analysis using
the CoLocalizer Pro software confirmed this: the colocalization
coefficient m1 was found to increase substantially during the
capping process. This indicates that a fraction of gE associates
with lipid rafts and that lipid raft association of gE increases
during antibody-mediated oligomerization and capping.
Discussion
Our results show that tyrosine phosphorylation of gE
increases during the viral capping process, that tyrosine
phosphorylation occurs in the cytoplasmic domain, at least
partly on the YXXΦ motifs, that Src kinases play a crucial role
Fig. 5. gE (Texas red staining) and GM1 (FITC staining) localization were assessed throughout the capping process (rim, patch, cap, extruded cap) by confocal analysis
and colocalization analysis. Colocalized pixels are located along the diagonal of the scatter gram and the colocalization coefficient m1 (value between 0 and 1)
indicates the fraction of red pixels that colocalize with green pixels, in other words, the fraction of gE that colocalizes with GM1 and thus with rafts.
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with lipid rafts and that lipid raft association of gE increases
during capping. These findings strongly suggest that alphaher-
pesvirus gE-mediated capping constitutes a viral mimicry of
immunoreceptor capping.
In addition, our findings shed a new light on a well-known
property of gE of different alphaherpesviruses (HSV, PRV and
VZV): its Fc receptor activity (Favoreel et al., 1997; Johnson et
al., 1988; Litwin et al., 1992). Fc receptor activity of
alphaherpesvirus gE has been shown to result in binding of
the Fc domain of IgG antibodies and has been shown to protect
virus and virus-infected cells from antibody-mediated elimina-
tion (Lubinski et al., 2002; Van de Walle et al., 2003). For
different Fc receptors of host organisms, such as Fcγ receptor II
(FcγRII) and the Fcα receptor, both primarily present on
monocytes, macrophages and neutrophils, IgG and IgA binding,
respectively, have been shown to lead to capping of the Fc
receptor and activation of the immune cell (Kwiatkowska et al.,
2003; Lang et al., 1999). During this capping process, the Fc
receptor is tyrosine phosphorylated on ITAM motifs in its
cytoplasmic domain, a process that relies on lipid rafts, all very
reminiscent to our current observations for gE-mediated
capping. In addition, the capping of FcγRII relies on a
rearrangement of the actin cytoskeleton, similar to what has
been described before for gE-mediated capping (Favoreel et al.,
1997).
Crosslinking and capping of FcγRII lead to activation of the
leukocytes, and culminate in initiation of effector mechanisms,
including generation of superoxide and oxidative burst,
chemotaxis, phagocytosis, degranulation of monocytes and
neutrophils (Katsumata et al., 2001; Lang et al., 1999; Scott-
Zaki et al., 2000). Seen the striking mechanistic similarity
between natural Fc receptor-mediated capping and capping
initiated by the alphaherpesvirus Fc receptor gE that we
describe here, it will be interesting to determine whether the
gE-mediated viral capping process may initiate similar effector
mechanisms as natural Fc receptors, which perhaps may allowthe virus to influence, interfere with or maybe even destabilize
the immune response.
We found that PRV gE is tyrosine phosphorylated in infected
SK cells. Tyrosine phosphorylation of BoHV1 and VZV gE has
been reported before (Olson et al., 1997; Shaw et al., 2000).
Interestingly, tyrosine phosphorylation of VZV gE was only
found in gE dimers (Olson et al., 1997). This is in line with our
current findings, which indicate that ‘artificial’ oligomerization
of PRV gE (by crosslinking via the addition of antibodies) leads
to increased tyrosine phosphorylation of gE. It will be interesting
to determine whether, similar to our current observations, Src
kinases may be involved in tyrosine phosphorylation of BoHV1
andVZV gE. Not much is known on the role of Src kinases in the
herpesvirus life cycle. Recently, the general state and role of Src
family kinases in replication of HSV1 was investigated (Liang
and Roizman, 2006). It was concluded that Src kinases play
significant, both positive and negative, roles in HSV1 replication
and that HSV1 proteins (e.g., ICP0, US3 and UL13) regulate the
activities of these kinases to achieve optimal viral yields in the
course of viral replication (Liang and Roizman, 2006). Our
finding that Src kinases play a role in tyrosine phosphorylation
of PRV gE during the capping process reveals an additional role
of these kinases during alphaherpesvirus infection.
Our finding that a fraction of PRV gE fractionates in lipid
rafts is also in agreement with recent reports that mention lipid
raft association of a fraction of gE of PRV (Favoreel et al., 2004;
Riteau et al., 2006).
We found that both gE association with lipid rafts and gE
tyrosine phosphorylation increased during capping. In addition,
we found that Src tyrosine kinases are critically involved in gE
tyrosine phosphorylation, and it has been reported earlier that
Src kinases Lck and Fyn exhibit optimal activity in raft
microdomains but encounter inhibitory conditions in non-raft
surrounding membrane areas (Ilangumaran et al., 1999).
Combining these data makes it tempting to speculate that gE
tyrosine phosphorylation predominantly occurs in lipid rafts.
Further experiments are planned to investigate this possibility.
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trifugation, to localize to lipid rafts may perhaps be an under-
estimation of the actual fraction of gE that localizes to rafts
since a significant fraction of the lipid raft marker GM1
localized to the non-raft region (Fig. 4). It is possible that, due
to the rather stringent detergent lysis conditions, some raft
components may be removed from the rafts during the
purification protocol. Alternatively, a fraction of GM1 and
possibly PRV gE may be associated with the so-called high-
density detergent-resistant membranes (DRM-H), which have
also recently been described during raft-purification in New-
castle disease virus-infected cells (Laliberte et al., 2006). The
DRM-H fraction is a class of detergent-resistant membranes
with higher buoyant densities than those of classical DRM,
such as classical lipid rafts. The higher density is due to their
association with the underlying membrane cytoskeleton.
Fractions of different other viral structural components
(envelope and tegument proteins) have also been reported to
associate with lipid rafts in alphaherpesvirus-infected cells, such
as PRV gB, HSV UL56, HSV vhs and HSV gH (Favoreel et al.,
2004; Koshizuka et al., 2002; Lee et al., 2003). Based on the
three-dimensional structure of isolated virions determined by
cryo-electron tomography, Grunewald and colleagues (2003)
proposed that lipid rafts in trans-Golgi network vesicles may
function as concentrating platforms for tegument proteins and
envelope proteins, thereby promoting successful assembly of
alphaherpesvirus particles.
In conclusion, we found that gE-mediated capping of
antibody–antigen complexes shows remarkable mechanistic
similarity to immunoreceptor capping, consisting of Src-




Mouse monoclonal antibody against gE (18E8) was
described earlier (Nauwynck and Pensaert, 1995) and was
used at a dilution 1:100. Polyclonal rabbit anti-mouse immuno-
globulins (DakoCytomation, Glostrup, Denmark) were used at
1:50. Mouse anti-transferrin receptor (TfR) was purchased from
Zymed Laboratories, Inc. (San Francisco, CA) and diluted
1:300. Texas red-labeled goat anti-mouse antibodies, fluores-
cein isothiocyanate (FITC)-labeled streptavidin (both used at a
dilution 1:50) and cholera toxin subunit B (CT-B) hrp conjugate
(dilution 1:200) were purchased from Molecular Probes
(Eugene, OR). Complete protease inhibitor cocktail was
purchased from Roche Diagnostics Gmbh, Mannheim, Ger-
many. Biotinylated cholera toxin B subunit (diluted 1:100),
Optiprep density gradient medium, Triton X-100, sodium
orthovanadate, sodium fluoride, phosphothreonine-BSA, phos-
photyrosine-BSA and phosphoserine-BSA were purchased
from Sigma (Sigma Chemical Co., St. Louis, MO). PP2 was
purchased from Biomol (Plymouth meeting, Pa), PP3 from
Calbiochem (San Diego, CA). The phospho-tyrosine mouse
monoclonal antibody (P-Tyr-100, Cell Signaling Technology,Danvers, MA) was used at 1:200. Biotinylated anti-mouse Ig
(dilution 1:300), streptavidin–biotin hrp complex (dilution
1:300), ECL Western blotting detection kit and rProtein A
Sepharose Fast Flow beads were all purchased from Amersham
Biosciences (Uppsala, Sweden).
Virus mutants
PRV strains Becker WT (Be WT) (Becker, 1967), a gE null
mutant (Whealy et al., 1993), a gE cytoplasmic domain minus
mutant (Be 107) and a strain with mutations in the YXXΦ
motifs of the cytoplasmic domain (Be 105: Y478S-Y517S)
(Tirabassi and Enquist, 1999) were used. Src kinase inhibitor
experiments were performed with the PRV-UL47 minus mutant
(Kopp et al., 2002).
Induction of capping
Capping was induced as described previously (Favoreel et
al., 1997), with some modifications in the antibodies that were
used. Briefly, SK cells were inoculated with PRV at a
multiplicity of infection (m.o.i.) 10 and 13 h post-inoculation
(p.i.), gE-specific mouse monoclonal antibodies (18E8) were
added to induce capping. Cells were incubated at 37 °C for
45 min, followed by a second antibody incubation with
polyclonal rabbit anti-mouse.
Tyrosine phosphorylation analysis
At 13 h p.i., capping was either or not induced in PRV
infected SK cells. Cells were lysed for 1 h at 37 °C in TNE
buffer (50 mM Tris–HCl, 150 mM NaCl, 1 mM EDTA, pH
6.8), containing 1% Triton X-100, complete protease inhibitor
cocktail, 10 mM sodium fluoride and 1 mM sodium
orthovanadate. Nuclei were removed by centrifugation and
samples were dissolved 1:2 in a 2× concentrated reducing
sodium dodecyl sulphate–polyacrylamide gel electrophoresis
(SDS–PAGE) loading buffer. 15 μl of each fraction was
subjected to SDS–PAGE (BioRad Mini Protean 3) and
Western blot (BioRad Mini Trans Blot). Blots were incubated
with the P-Tyr-100 antibody in Tris-buffered solution with
0.1% Tween-20 (TBS/Tween) and 5% BSA overnight at 4°,
followed by biotinylated anti-mouse Ig and streptavidin–
biotin hrp complex. gE expression was analyzed by incu-
bation of the blot with the mouse monoclonal 18E8 antibody
in PBS, followed by the same secondary and tertiary
conjugate as for the phosphorylation analysis. Blots were
developed with the ECL Western blotting detection kit.
Quantity One Analysis Software (Bio-Rad) was used to
determine the average increase in gE tyrosine phosphoryla-
tion after capping induction on blots from 3 independent
experiments.
Immunoprecipitation of gE
After induction of capping with the 18E8 gE antibody and
polyclonal rabbit anti-mouse, gE was immunoprecipitated out
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prewashed rProtein A Sepharose Fast Flow beads. After three
PBS washings, immunoprecipitated gE was released from the
beads by boiling in 2× concentrated reducing SDS–PAGE
loading buffer and gE tyrosine phosphorylation was analyzed
on Western blot as described above.
Specificity testing of P-Tyr-100 antibody
0.1 μg of phosphotyrosine-BSA, phosphothreonine-BSA or
phosphoserine-BSA were loaded on an SDS–PAGE gel and
blotted. The blot was incubated with the P-Tyr-100 antibody,
biotinylated anti-mouse Ig and streptavidin–biotin hrp, fol-
lowed by ECL development.
Src kinase inhibitor treatment
At 13 h p.i., PRV-inoculated cells were incubated 30 min at
37 °C with 0, 0.1, 1, 10 or 100 μM of the Src kinase inhibitor
PP2 or its negative control PP3. Afterwards, capping was
induced as described above in the presence of the same
concentration of the inhibitors and tyrosine phosphorylation
analysis was performed as described above.
Purification of lipid rafts by density ultracentrifugation
Lipid rafts were purified as described previously (Favoreel et
al., 2004), with some small modifications. Briefly, cells were
lysed at 4 °C in TNE buffer (25 mM Tris–HCl, 150 mM NaCl,
5 mM EDTA, pH 6.7) containing 1% Triton X-100 and
complete protease inhibitor cocktail for 30 min. After homo-
genization with a 25-G syringe, the lysate was mixed with ice-
cold iodixanol (Optiprep) up to 40% iodixanol and overlayed
with 5 mL 30% iodixanol (ice-cold) and 3 mL 5% iodixanol
(ice-cold). Gradients were subjected to ultracentrifugation at
200000 g, 4 °C for 20 h in the SW41Ti rotor of a Beckman
ultracentrifuge (Beckman, Munich, Germany). Ten to twelve
fractions were collected from top to bottom, diluted 1:2 in 2×
concentrated non-reducing SDS–PAGE loading buffer and
subjected to SDS–PAGE and Western blot. Blots were
incubated with the appropriate antibodies or conjugates for
detection of gE (18E8), TfR and GM1 (CT-B hrp) and
developed with ECL.
Fluorescence staining for assessing lipid raft association
For fluorescence experiments, capping was induced only
with the 18E8 anti-gE monoclonal antibody. Thereafter,
cells were fixed with 3% paraformaldehyde at room
temperature and washed with PBS. After a 1-h incubation
with biotinylated cholera toxin B subunit, cells were
washed with PBS again and stained subsequently with
streptavidin–FITC and goat anti-mouse Texas red. After
washing in PBS, cells were mounted in a glycerin-PBS
solution (0.9:0.1, vol:vol) with 2.5% 1,4,-diazabicyclo(2.2.2)
octane (Janssen Chimica, Beerse, Belgium) and analyzed by
confocal microscopy.Confocal microscopy
Cells were analyzed by using a TCS SP2 laser scanning
spectrum confocal system (Leica Microsystems, GmbH,
Heidelberg, Germany), using an Argon 488 nm laserline and
a Gre/Ne 543 nm laser line to excite FITC and Texas red,
respectively. To avoid signal overlap, FITC and Texas red
images were taken separately. Images were merged using Leica
confocal and Confocal Assistant software (Todd Clark Brelje).
Colocalization was quantified by the CoLocalizer Pro software
(CoLocalization Research Software).
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